// App-Quantinova.ai

2475 : Bortezomib Can Overcome Stroma-Mediated Chemotherapy Resistance in Acute Lymphoblastic Leukemia.

Researchers

Presenter

  • Julie Ritchey

Principal Investigators

  • Matthew Holt

  • John F. DiPersio

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • B-cell acute lymphoblastic leukemia

  • Multiple Myeloma

Biomarkers

  • Breakpoint Cluster Region

  • C-X-C motif chemokine receptor 4

Drug/Treatment

  • Doxorubicin

  • Bortezomib

  • Cytarabine liposomal

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved